More accurate diagnosis by new DNA-reading technique

A groundbreaking DNA sequencing technique known as long-read sequencing has emerged as a powerful tool for more accurate diagnosis of a wide range of rare genetic disorders, including Huntington's disease and certain forms of dementia. The method allows scientists to read lengthy DNA fragments, up to 10,000 bases, in a single test, enabling them to detect complex features such as variations and rearrangements. This advancement was highlighted in a study published in the journal Nature Genetics by the international consortium Lrs-Red (Long-Read Sequencing in Repeat-Expansion Disorders), led by Paris’s Sorbonne University. Italian institutions, including the Universities of Verona and Rome Tor Vergata, were also involved in the research. Genetic diseases like Huntington’s are caused by abnormal expansions of short DNA sequences. However, counting how many times these sequences repeat does not fully explain characteristics of these conditions, such as the age of onset and severity. Researchers led by Stéphanie Tomé emphasized that obtaining precise diagnoses requires considering how interruptions can occur within the repeated sequence or how the expansion might vary in length across different tissues in the same patient. Such detailed information can only be obtained through long-read sequencing. "For 30 years, we have diagnosed these diseases by counting repetitions," said Giuseppe Novelli, a geneticist from Rome’s Tor Vergata University and a co-author of the study. "For 30 years, we wondered why two patients with the same number of repetitions had different clinical histories. Today, we know the answer was written inside the expansion itself, in details our tools could not read before. Long-read sequencing gives us back those details. It represents a change in diagnosis, but especially the possibility of telling a patient what to expect and choosing the right therapy for him when it becomes available." The new technology addresses limitations of traditional short-read sequencing methods, which often fail to capture the full complexity of expanded repeats. By providing a more comprehensive view of the genome, long-read sequencing enables clinicians to better understand the underlying mechanisms of these diseases and potentially tailor treatments to individual patients. Researchers noted that the ability to analyze longer DNA segments offers insights into previously undetectable genetic variations that may influence disease progression. These findings could lead to improved diagnostic accuracy and more personalized treatment strategies for individuals affected by these conditions. Experts suggest that the application of this technology will likely expand beyond the current scope of the study. As the cost of long-read sequencing continues to decrease and its accessibility improves, it is anticipated that more medical centers around the world will adopt this approach for routine genetic testing. This shift could significantly impact the management and treatment of genetic disorders, offering patients clearer prognoses and more targeted therapeutic options. The study underscores the importance of continued investment in genomic research and the development of advanced sequencing technologies. Collaborations between academic institutions and healthcare providers are crucial in translating these scientific breakthroughs into practical applications that benefit patients directly. As the field progresses, further studies will aim to validate the effectiveness of long-read sequencing in diagnosing a broader spectrum of genetic conditions and evaluating its potential in guiding clinical decision-making.